Thanks to all those who have submitted an abstract for the 2022 IHN-SHOT Symposium. These are being judged at present and the outcome will be notified to the submitting authors by close of play this Friday 17th June 2022.
The IHN and the SHOT team invite and encourage the submission of original, unpublished material for consideration as a presentation at the IHN-SHOT symposium 2022. The Symposium will be held face to face in Brighton in addition to being live streamed on the symposium website.
Why not submit an abstract and share your best practice, recent surveillance outcomes, and/or research?
A limited number of main authors of accepted abstracts will be chosen to receive complimentary registration for the conference.
Areas of interest are:
- Transfusion education
- Quality assurance and audit
- Incident investigation and human factors
- Innovation and quality improvement projects
- Organisational aspects of haemovigilance systems
- Haemovigilance implementation (national, regional, or local)
- Transfusion medicine and haemovigilance
- Donor vigilance: Long term effects of donation
- Donor vigilance: Plasma vigilance
- Biovigilance of non-blood derived medical products of human origin
- Emerging infectious diseases
Abstracts can only be accepted if received in the requested format. To submit an abstract please click here.
Abstracts are invited for poster and oral presentations at the IHN- SHOT Symposium, 6 -8th July at the Hilton Brighton Metropole, Kings Rd, Brighton BN1 2FU. Abstracts must be original and must not have been previously published or presented at other British meetings with the exception of British Blood.
It has been agreed that abstracts may be presented at both the British Blood Transfusion Society (BBTS) Annual Scientific Meeting and the IHN-SHOT Symposium.
Abstracts should be no longer than 500 words excluding abstract title and authors and will be subject to review by the abstract review process. Top scoring abstracts will be selected for 10-minute oral presentations as part of the symposium programme.
Your abstract must set out clearly the purpose of the study and must include data to support your conclusions and should include page numbers.
Abstracts should include:
- Background/Introduction – a brief statement of purpose or why the study was done;
- Methods or Study Design – a description of the methods used or work done;
- Results – a summary of the results observed;
- Conclusions – a statement of the conclusions based on the reported results, including any recommendations.
The abstract should arrive in four sections as above.
Data should be summarised, abstracts should include numbers studied etc, “results will be discussed” or “data will be presented” is not sufficient and may lead to the abstract being rejected.
– State the reason for the study/research/Educational project / Quality improvement project
– Describe methods and/or study design
– Present data and results clearly
– Interpret results and state their significance
– Explain terms before abbreviating them
Reviewers may reject abstracts because;
– The data are considered insufficient
– The conclusion cannot be reached from the data presented
– The abstract is poorly presented with spelling or grammatical errors – Write clearly and concisely
Submission of an abstract constitutes a commitment by the author to present it if accepted. Failure to present, if not justified, may put future abstract submissions at risk. The presenter must register and attend the annual symposium.
References are discouraged, however if references are essential, they should be within the text, in the form: (Smith et al. Eur J Anaesth 1998; 15: 100-1).
All submitting authors will receive an e-mail confirmation of the receipt of their submission.
Reviewing of the abstracts will take place directly after submission.
Authors will be notified of the outcome of their submissions by the 10th June 2022